Loading…
Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development
Posology—the science of dose and regimen—is a critical part of drug development. It is concerned with ensuring that patients experience significant clinical benefit without intolerable adverse effects. It has become apparent, in the case of certain biologics, that one can directly quantitate occupan...
Saved in:
Published in: | Clinical pharmacology and therapeutics 2010-04, Vol.87 (4), p.492-496 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613 |
---|---|
cites | cdi_FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613 |
container_end_page | 496 |
container_issue | 4 |
container_start_page | 492 |
container_title | Clinical pharmacology and therapeutics |
container_volume | 87 |
creator | Lowe, PJ |
description | Posology—the science of dose and regimen—is a critical part of drug development. It is concerned with ensuring that patients experience significant clinical benefit without intolerable adverse effects. It has become apparent, in the case of certain biologics, that one can directly quantitate occupancy or target capture and relate these to clinical responses. With mathematical models that integrate binding concepts with clinical effects, potential posologies can be quickly explored through simulation, thereby liberating research teams from the traditional constraints and simultaneously stimulating innovation. |
doi_str_mv | 10.1038/clpt.2009.302 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733583392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733583392</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613</originalsourceid><addsrcrecordid>eNp9kDtv2zAURomiQeM4HbMG6lBkksOHHuSYym0SwIA9OOhIUNSVzYISVVFq4f76SJXtbJkuvovzXRIHoRuCFwQzfq9t0y0oxmLBMP2AZiRmNExiFn9EMzysQ0FZcomuvP81xEhw_gldUkyilIt0hn4-NI09mHoXbPYHb5x1O6OVDVRdBN-M03uo_ufM1RqazgedC9ZNZyrzD0bgxC_bfhcs4Q9Y11RQd9foolTWw-fjnKOXH9-32VO4Wj8-Zw-rUDPBaZjmWAuImNJJlEcCpzqKqIAijigriBBcJYqwIs11TKFIFSc5TXLgOSa0LBPC5uhuutu07ncPvpOV8RqsVTW43suUsZgzNkiYo3Aideu8b6GUTWsq1R4kwXJUKUeVclQpB5UDf3u83OcVFGf65G4Avh4B5QcFZatqbfwbR2NB0jgZODFxf42Fw_uvymyzzVab7ZinT3yZurXq-hbO5bF0Yl4BWI-Zug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733583392</pqid></control><display><type>article</type><title>Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Lowe, PJ</creator><creatorcontrib>Lowe, PJ</creatorcontrib><description>Posology—the science of dose and regimen—is a critical part of drug development. It is concerned with ensuring that patients experience significant clinical benefit without intolerable adverse effects. It has become apparent, in the case of certain biologics, that one can directly quantitate occupancy or target capture and relate these to clinical responses. With mathematical models that integrate binding concepts with clinical effects, potential posologies can be quickly explored through simulation, thereby liberating research teams from the traditional constraints and simultaneously stimulating innovation.</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/clpt.2009.302</identifier><identifier>PMID: 20147897</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Biological and medical sciences ; Biological Products - administration & dosage ; Biological Products - adverse effects ; Biological Products - pharmacology ; Clinical Trials as Topic - methods ; Computer Simulation ; Dose-Response Relationship, Drug ; Drug Design ; Humans ; Medical sciences ; Models, Biological ; Pharmacology. Drug treatments</subject><ispartof>Clinical pharmacology and therapeutics, 2010-04, Vol.87 (4), p.492-496</ispartof><rights>2010 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613</citedby><cites>FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22591756$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20147897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lowe, PJ</creatorcontrib><title>Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Posology—the science of dose and regimen—is a critical part of drug development. It is concerned with ensuring that patients experience significant clinical benefit without intolerable adverse effects. It has become apparent, in the case of certain biologics, that one can directly quantitate occupancy or target capture and relate these to clinical responses. With mathematical models that integrate binding concepts with clinical effects, potential posologies can be quickly explored through simulation, thereby liberating research teams from the traditional constraints and simultaneously stimulating innovation.</description><subject>Biological and medical sciences</subject><subject>Biological Products - administration & dosage</subject><subject>Biological Products - adverse effects</subject><subject>Biological Products - pharmacology</subject><subject>Clinical Trials as Topic - methods</subject><subject>Computer Simulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Design</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>Pharmacology. Drug treatments</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kDtv2zAURomiQeM4HbMG6lBkksOHHuSYym0SwIA9OOhIUNSVzYISVVFq4f76SJXtbJkuvovzXRIHoRuCFwQzfq9t0y0oxmLBMP2AZiRmNExiFn9EMzysQ0FZcomuvP81xEhw_gldUkyilIt0hn4-NI09mHoXbPYHb5x1O6OVDVRdBN-M03uo_ufM1RqazgedC9ZNZyrzD0bgxC_bfhcs4Q9Y11RQd9foolTWw-fjnKOXH9-32VO4Wj8-Zw-rUDPBaZjmWAuImNJJlEcCpzqKqIAijigriBBcJYqwIs11TKFIFSc5TXLgOSa0LBPC5uhuutu07ncPvpOV8RqsVTW43suUsZgzNkiYo3Aideu8b6GUTWsq1R4kwXJUKUeVclQpB5UDf3u83OcVFGf65G4Avh4B5QcFZatqbfwbR2NB0jgZODFxf42Fw_uvymyzzVab7ZinT3yZurXq-hbO5bF0Yl4BWI-Zug</recordid><startdate>201004</startdate><enddate>201004</enddate><creator>Lowe, PJ</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201004</creationdate><title>Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development</title><author>Lowe, PJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Biological Products - administration & dosage</topic><topic>Biological Products - adverse effects</topic><topic>Biological Products - pharmacology</topic><topic>Clinical Trials as Topic - methods</topic><topic>Computer Simulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Design</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lowe, PJ</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lowe, PJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2010-04</date><risdate>2010</risdate><volume>87</volume><issue>4</issue><spage>492</spage><epage>496</epage><pages>492-496</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><abstract>Posology—the science of dose and regimen—is a critical part of drug development. It is concerned with ensuring that patients experience significant clinical benefit without intolerable adverse effects. It has become apparent, in the case of certain biologics, that one can directly quantitate occupancy or target capture and relate these to clinical responses. With mathematical models that integrate binding concepts with clinical effects, potential posologies can be quickly explored through simulation, thereby liberating research teams from the traditional constraints and simultaneously stimulating innovation.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>20147897</pmid><doi>10.1038/clpt.2009.302</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9236 |
ispartof | Clinical pharmacology and therapeutics, 2010-04, Vol.87 (4), p.492-496 |
issn | 0009-9236 1532-6535 |
language | eng |
recordid | cdi_proquest_miscellaneous_733583392 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Biological and medical sciences Biological Products - administration & dosage Biological Products - adverse effects Biological Products - pharmacology Clinical Trials as Topic - methods Computer Simulation Dose-Response Relationship, Drug Drug Design Humans Medical sciences Models, Biological Pharmacology. Drug treatments |
title | Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A48%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Applying%20Physiological%20and%20Biochemical%20Concepts%20to%20Optimize%20Biological%20Drug%20Development&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Lowe,%20PJ&rft.date=2010-04&rft.volume=87&rft.issue=4&rft.spage=492&rft.epage=496&rft.pages=492-496&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1038/clpt.2009.302&rft_dat=%3Cproquest_cross%3E733583392%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3982-7b0c9e43ac64b4907c4429ed5423d1998a6a13d7bc52ed7a81b26be8b012ff613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733583392&rft_id=info:pmid/20147897&rfr_iscdi=true |